Fig. 8: The In vivo recognition of Her2 (+) tumors and the antitumor effects of iMSCEndostatin.

A Recognition of solid tumors by iMSCEndostatin. B–D Recognition of tumors by iMSCEndostatin in lung metastasis models. E–G Images of tumor in model mice after iMSCEndostatin treatment, as well as tumor weight and volume. H, I CD34 staining of tumor sections in model mice after iMSCEndostatin treatment.